(Q74547010)

English

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

scientific article published on 01 August 2002

In more languages
default for all languages
No label defined

No description defined

Statements

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit